These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27916229)

  • 1. Corrigendum to: "Long-term leptin treatment exerts a pro-apoptotic effect on renal tubular cells via prostaglandin E2 augmentation" [Eur. J. Pharmacol. 689 (2012) 65-71].
    Hsu YH; Cheng CY; Chen YC; Chen TH; Sue YM; Tsai WL; Chen CH
    Eur J Pharmacol; 2016 Dec; 792():79. PubMed ID: 27916229
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term leptin treatment exerts a pro-apoptotic effect on renal tubular cells via prostaglandin E2 augmentation.
    Hsu YH; Cheng CY; Chen YC; Chen TH; Sue YM; Tsai WL; Chen CH
    Eur J Pharmacol; 2012 Aug; 689(1-3):65-71. PubMed ID: 22713546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Tenuigenin exhibits protective effects against LPS-induced acute kidney injury via inhibiting TLR4/NF-κB signaling pathway" [Eur. J. Pharmacol. 791 (2016) 229-234].
    Haiyan F; Zhansheng H; Xingwei D; Qiuhong Z; Rongbin Z; Hongyang D
    Eur J Pharmacol; 2016 Dec; 792():78. PubMed ID: 27916228
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Tumor suppression effects of myoepithelial cells on mice breast cancer" [Eur. J. Pharmacol. 765 (2015) 171-178].
    Farhangi B; Latifpour M; Alizadeh AM; Khodayari H; Khodayari S; Khaniki M; Ghasempour S
    Eur J Pharmacol; 2016 Jul; 782():119. PubMed ID: 27180042
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice" [Eur. J. Pharmacol. 666 (2011) 196-204].
    Li JM; Zhang X; Wang X; Xie YC; Kong LD
    Eur J Pharmacol; 2022 Feb; 916():174740. PubMed ID: 34996605
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes" [Eur. J. Pharmacol. 776 (2016) 26-33].
    Guo Y; Zhang L; Li F; Hu CP; Zhang Z
    Eur J Pharmacol; 2016 Jul; 782():120. PubMed ID: 27180043
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to 'Antitumor effects of seleno-β-lactoglobulin (Se-β-Lg) against human gastric cancer MGC-803 cells' [Eur. J. Pharmacol. 833 (2018) 109-115].
    Yu J; Dong X; Wang LL; Ji H; Liu A
    Eur J Pharmacol; 2019 Mar; 846():128-130. PubMed ID: 30409420
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver: [Eur.J.Pharmacol.789(2016)60-67].
    Lu CH; Hung YJ; Hsieh PS
    Eur J Pharmacol; 2018 Jan; 819():292. PubMed ID: 29325910
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Pretreatment with obestatin reduces the severity of ischemia/reperfusion-induced acute pancreatitis in rats" [Eur. J. Pharmacol. 760 (2015) 113-121].
    Bukowczan J; Warzecha Z; Ceranowicz P; Kuśnierz-Cabala B; Tomaszewska R; Dembinski A
    Eur J Pharmacol; 2019 Jan; 842():384-385. PubMed ID: 30554633
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin pathway" [Eur. J. Pharmacol. 865 (2019) 172787].
    Li LY; Yang CC; Yang JF; Li HD; Zhang BY; Zhou H; Hu S; Wang K; Huang C; Meng XM; Zhou H; Zhang L; Li J; Xu T
    Eur J Pharmacol; 2020 Feb; 869():172848. PubMed ID: 31843196
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to 'Echinocystic acid, a natural plant extract, alleviates cerebral ischemia/reperfusion injury via inhibiting the JNK signaling pathway' [Eur. J. Pharmacol., 861 (2019 oct 15), 172610].
    Yu H; Li W; Cao X; Wang X; Zhao Y; Song L; Chen J; Wang S; Chen B; Xu Y
    Eur J Pharmacol; 2021 Feb; 892():173790. PubMed ID: 33308992
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to: "Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice": [Eur.J.Pharmacol.670(2011)441-447].
    Tsai SJ; Chao CY; Yin MC
    Eur J Pharmacol; 2018 Jan; 819():293. PubMed ID: 29325911
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression" [Eur. J. Pharmacol. (2021) 890 173669].
    Hua D; Zhao Q; Yu Y; Yu H; Yu L; Zhou X; Wang Q; Sun C; Shi C; Luo W; Jiang Z; Wang W; Wang L; Zhang D; Tang S; Yu S
    Eur J Pharmacol; 2022 Apr; 921():174897. PubMed ID: 35292175
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "A novel flavonoid isolated from the steam-bark of Ulmus wallichiana planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation" [Eur. J. Pharmacol. 658(2-3) 2011 65-73].
    Swarnkar G; Sharan K; Siddiqui J; Chakravarti B; Rawat P; Kumar M; Arya KR; Maurya R; Chattopadhyay N
    Eur J Pharmacol; 2018 Jul; 831():103-105. PubMed ID: 29803358
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Diethyl-4,4'-dihydroxy-8,3'-neolign-7,7'-dien-9,9'-dionate exhibits antihypertensive activity in rats through increase in intracellular cGMP level and blockade of calcium channels" [Eur. J. Pharmacol. 799 (2017) 84-93].
    Singh A; Kumar BS; Alam S; Iqbal H; Shafiq M; Khan F; Negi AS; Hanif K; Chanda D
    Eur J Pharmacol; 2017 Jul; 806():111. PubMed ID: 28495016
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to 'Reduced nitric oxide-mediated relaxation and endothelial nitric oxide synthase expression in the tail arteries of streptozotocin-induced diabetic rats' [Eur. J. Pharmacol. 773 (2016) 78-84].
    Mokhtar SS; Vanhoutte PM; Leung SWS; Suppian R; Yusof MI; Rasool AHG
    Eur J Pharmacol; 2017 Oct; 812():264. PubMed ID: 28915977
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Flaccidoside II ameliorates collagen-induced arthritis in mice" [Eur. J. Pharmacol. 880 (2020) 173155].
    Zhang GB; Jia ZJ; Zhang MH; Li YJ; Tian LY; Cheng J
    Eur J Pharmacol; 2021 Apr; 897():173963. PubMed ID: 33674037
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Vitexin protects against ethanol-induced liver injury through Sirt1/p53 signaling pathway" [Eur. J. Pharmacol. 873 (2020) 173007].
    Yuan H; Duan S; Guan T; Yuan X; Lin J; Hou S; Lai X; Huang S; Du X; Chen S
    Eur J Pharmacol; 2020 Aug; 880():173160. PubMed ID: 32460965
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "siRNA: Mechanism of action, challenges, and therapeutic approaches" [Eur. J. Pharmacol. 905 (2021) 174178].
    Alshaer W; Zureigat H; Al Karaki A; Al-Kadash A; Gharaibeh L; Hatmal MM; Aljabali AAA; Awidi A
    Eur J Pharmacol; 2022 Feb; 916():174741. PubMed ID: 34998574
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "The Ω-3 fatty acid docosahexaenoic acid selectively induces apoptosis in tumor-derived cells and suppress tumor growth in gastric cancer" [Eur. J. Pharmacol. (2021) 173910].
    Ortega L; Lobos-González L; Reyna-Jeldes M; Cerda D; De la Fuente-Ortega E; Castro P; Bernal G; Coddou C
    Eur J Pharmacol; 2021 Sep; 906():174287. PubMed ID: 34183147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.